The global sequencing consumables market size was valued at USD 6.94 billion in 2023 and is expected to reach around USD 50.75 billion by 2033 with a CAGR of 18.14% from 2024 to 2033.
Key Takeaways
- Asia Pacific is expected to witness the fastest rate of growth in the sequencing consumables market during the forecast period.
- By product, the kits segment held the largest segment of the sequencing consumables market in 2023.
- By product, the reagents segment is expected to grow at a significant rate during the forecast period.
- By platform, the second-generation sequencing consumables segment is expected to hold the dominating share of the market.
- By platform, the third-generation sequencing consumables segment is expected to grow at a notable rate.
- By application, the cancer diagnostics segment is expected to hold the dominating share of the market during the forecast period.
- By application, the pharmacogenomics segment is expected to grow at a notable rate.
The sequencing consumables market plays a pivotal role in supporting advancements in genomics and molecular biology. As an integral component of DNA sequencing processes, consumables encompass a range of products such as reagents, sample preparation kits, and other laboratory supplies. This market is characterized by its dynamic nature, driven by the continuous evolution of sequencing technologies and the growing demand for genomic insights in various scientific disciplines.
Get a Sample: https://www.precedenceresearch.com/sample/3679
Growth Factors
The growth of the sequencing consumables market is propelled by the increasing adoption of next-generation sequencing (NGS) techniques across research, clinical diagnostics, and pharmaceutical applications. The rise in personalized medicine, coupled with decreasing costs of sequencing, further fuels the demand for consumables. Technological innovations, such as high-throughput sequencing platforms, contribute to market expansion by enhancing the efficiency and speed of sequencing workflows.
Sequencing Consumables Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 18.14% |
| Global Market Size in 2023 | USD 6.94 Billion |
| Global Market Size by 2033 | USD 50.75 Billion |
| U.S. Market Size in 2023 | USD 2.53 Billion |
| U.S.Market Size by 2033 | USD 13.39 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Platform, and By Application |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Plastic Processing Machinery Market Size to Attain USD 35.58 Bn By 2033
Market Dynamics
Drivers:
Several factors drive the demand for sequencing consumables, including the surge in genomic research initiatives, a growing awareness of precision medicine, and the escalating prevalence of genetic disorders. The expansion of research and development activities in life sciences and biotechnology also acts as a major driver. Additionally, the widening scope of applications in areas like oncology, agriculture, and forensics amplifies the need for reliable and efficient sequencing consumables.
Opportunities:
Opportunities within the sequencing consumables market lie in the untapped potential of emerging economies, where increasing healthcare infrastructure and research investments create a conducive environment for market growth. Continuous product innovations, such as improved reagents and streamlined sample preparation kits, present opportunities for market players to stay competitive. Collaborations between industry stakeholders and research institutions can foster innovation and create novel avenues for market expansion.
Challenges:
The sequencing consumables market faces challenges related to stringent regulatory requirements and quality standards, particularly in the context of clinical applications. Price pressure due to intense market competition poses a challenge for manufacturers. Additionally, addressing the ethical considerations associated with the use of genomic data and ensuring data privacy remain ongoing challenges that impact the market’s trajectory. Navigating these challenges requires a strategic approach and ongoing commitment to quality and compliance.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Recent developments in the Sequencing Consumables Market
- In October 2022, Illumina (US) collaborated with GenoScreen (France) to extend genomic testing accessibility for multidrug-resistant tuberculosis, particularly in countries heavily affected by tuberculosis. This partnership aims to enhance diagnostic capabilities and contribute to the global effort to combat tuberculosis.
- In October 2022, Illumina (US) entered into a strategic research collaboration with AstraZeneca (UK). The partnership focuses on improving pharmaceutical pipelines by leveraging genomic insights to identify genetic variants associated with human diseases. This collaboration underscores the increasing importance of genomics in drug development and precision medicine.
- In September 2022, Thermo Fisher Scientific (US) achieved FDA approval for the Oncomine Dx Target Test. This marked a milestone as the first Next-Generation Sequencing (NGS)-based companion diagnostic, designed to aid in therapy selection for patients with RET mutations/fusions in thyroid cancers. The FDA approval highlights the growing role of genomics in guiding personalized treatment decisions for cancer patients.
Sequencing Consumables Market Companies
- Illumina, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Qiagen N.V. (Netherlands)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Agilent Technologies, Inc. (US)
- Pacific Biosciences of California, Inc. (US)
- PerkinElmer, Inc. (US)
- Oxford Nanopore Technologies Ltd. (UK)
- Bio-Rad Laboratories, Inc. (US)
- BGI Genomics Co., Ltd. (China)
- GenScript Biotech Corporation (China)
- Eurofins Scientific (Luxembourg)
- Macrogen Inc. (South Korea)
- New England Biolabs, Inc. (US)
- Swift Biosciences, Inc. (US)
Segments Covered in the Report
By Product
- Kits
- Reagents
- Accessories
By Platform
- 1st Generation sequencing consumables
- 2nd Generation sequencing consumables
- 3rd Generation sequencing consumables
By Application
- Cancer Diagnostics
- Infectious Disease Diagnostics
- Reproductive Health Diagnostics
- Pharmacogenomics
- Agrigenomics
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Sequencing Consumables Market
5.1. COVID-19 Landscape: Sequencing Consumables Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Sequencing Consumables Market, By Product
8.1. Sequencing Consumables Market Revenue and Volume, by Product, 2024-2033
8.1.1 Kits
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Reagents
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Accessories
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Sequencing Consumables Market, By Platform
9.1. Sequencing Consumables Market Revenue and Volume, by Platform, 2024-2033
9.1.1. 1st Generation sequencing consumables
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. 2nd Generation sequencing consumables
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. 3rd Generation sequencing consumables
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Sequencing Consumables Market, By Application
10.1. Sequencing Consumables Market Revenue and Volume, by Application, 2024-2033
10.1.1. Cancer Diagnostics
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Infectious Disease Diagnostics
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Reproductive Health Diagnostics
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Pharmacogenomics
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Agrigenomics
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Sequencing Consumables Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
Chapter 12. Company Profiles
12.1. Illumina, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Thermo Fisher Scientific Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Qiagen N.V
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. F. Hoffmann-La Roche Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Agilent Technologies, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Pacific Biosciences of California, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. PerkinElmer, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Oxford Nanopore Technologies Ltd.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. BGI Genomics Co., Ltd.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/
